FDA Approved: LEVETIRACETAM — Supplemental Application (Major Pharmaceuticals)

View source ↗

Summary

FDA supplemental application approval for levetiracetam (Major Pharmaceuticals) under ANDA201157.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizure Disorders

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)